Literature DB >> 22548620

Autoimmune neuropathies: insights from animal models.

Betty Soliven1.   

Abstract

Autoimmune neuropathies comprise a diverse group of conditions resulting from an immune attack on the peripheral nervous system. In some of these disorders, the antigenic target has been identified. In other conditions such as chronic inflammatory demyelinating polyradiculoneuropathy, the initial trigger and the antigenic target remain elusive. Animal models have provided some important information regarding their pathogenetic mechanisms. This review summarizes the background information and recent highlights from studies in animal models such as experimental autoimmune neuritis and spontaneous autoimmune polyneuropathy in B7-2 knockout non-obese diabetic mice.
© 2012 Peripheral Nerve Society.

Entities:  

Mesh:

Year:  2012        PMID: 22548620     DOI: 10.1111/j.1529-8027.2012.00392.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  8 in total

Review 1.  Institutional animal care and use committee considerations for animal models of peripheral neuropathy.

Authors:  Thea Brabb; Larry Carbone; Jessica Snyder; Nona Phillips
Journal:  ILAR J       Date:  2014

2.  Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.

Authors:  John W Rumsey; Case Lorance; Max Jackson; Trevor Sasserath; Christopher W McAleer; Christopher J Long; Arindom Goswami; Melissa A Russo; Shruti M Raja; Karissa L Gable; Doug Emmett; Lisa D Hobson-Webb; Manisha Chopra; James F Howard; Jeffrey T Guptill; Michael J Storek; Miguel Alonso-Alonso; Nazem Atassi; Sandip Panicker; Graham Parry; Timothy Hammond; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2022-04-05

3.  Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.

Authors:  Bangwei Luo; Fuyu Han; Kai Xu; Jinsong Wang; Zongwei Liu; Zigang Shen; Jia Li; Yu Liu; Man Jiang; Zhi-Yuan Zhang; Zhiren Zhang
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

4.  Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.

Authors:  Xianzhen Hu; V Michael Holers; Joshua M Thurman; Trent R Schoeb; Theresa N Ramos; Scott R Barnum
Journal:  Mol Immunol       Date:  2013-01-20       Impact factor: 4.407

5.  Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study.

Authors:  Velina Nedkova; Gerardo Gutiérrez-Gutiérrez; Francisco J Navacerrada-Barrero; José Berciano; Carlos Casasnovas
Journal:  Acta Neurol Belg       Date:  2021-02-18       Impact factor: 2.396

6.  Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection.

Authors:  Yuqi Liu; Bangwei Luo; Fuyu Han; Xiaoming Li; Jian Xiong; Man Jiang; Xioafeng Yang; Yuzhang Wu; Zhiren Zhang
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

7.  Capsaicin-enriched diet ameliorates autoimmune neuritis in rats.

Authors:  Jeremias Motte; Björn Ambrosius; Thomas Grüter; Hussein Bachir; Melissa Sgodzai; Xiomara Pedreiturria; Kalliopi Pitarokoili; Ralf Gold
Journal:  J Neuroinflammation       Date:  2018-04-24       Impact factor: 8.322

8.  Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study.

Authors:  José Berciano; Pedro Orizaola; Elena Gallardo; Ana L Pelayo-Negro; Pascual Sánchez-Juan; Jon Infante; María J Sedano
Journal:  Clin Neurophysiol Pract       Date:  2019-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.